CBD Enhances Glucose Metabolism via Nuclear Receptors

Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. Several phytocannabinoids, including cannabidiol (CBD), for example, and the two primary endocannabinoids — anandamide and 2-AG — have been shown to interact with peroxisome proliferator-activated receptors, or PPARs1 (pronounced pee-parrs), which are … Read more

PubMed: Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

Data science and data engineering are two crucial fields that have been used to help us better understand the effects of cannabidiol (CBD) on the brain. Recent research has shown that CBD can be used to improve cerebral glucose utilization and reduce psychopathology and cognitive deficits in patients with high-risk mental states. CBD is a … Read more